Preparation, release profiles, and antibacterial properties of vancomycin-loaded poly(D,L-lactic) titanium alloy plates

Orthopedics

Volumn 32, Issue 5, 2009, Pages 324-

  Tang, LiangHua ^a   Zhao, ChangHong ^b   Xiong, Yan ^a   Pan, ChangJiang ^b   Wang, AiMin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Bioengineering College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

POLYLACTIC ACID; TITANIUM; VANCOMYCIN; ALLOY; ANTIINFECTIVE AGENT; BIOMATERIAL;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; BONE DEFECT; BONE PLATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HOSPITAL INFECTION; IN VITRO STUDY; INFECTION; INFECTION RATE; INFECTION RISK; NONHUMAN; OPEN FRACTURE; OSTEOMYELITIS; OSTEOSYNTHESIS; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; TIBIA FRACTURE; TUBERCULOUS OSTEOMYELITIS; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DIFFUSION; DRUG EFFECT;

ALLOYS; ANTI-BACTERIAL AGENTS; BONE PLATES; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DIFFUSION; STAPHYLOCOCCUS AUREUS; TITANIUM; VANCOMYCIN;

EID: 68849097328     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20090501-16     Document Type: Article

References (34)

1. Bauer TW, Schils J. The pathology of total joint arthroplasty. I. Mechanisms of implant fixation. Skeletal Radiol. 1999; 28(8):423-432.
2. Bauer TW, Schils J. The pathology of total joint arthroplasty. II. Mechanisms of implant failure. Skeletal Radiol. 1999; 28(9):483-497.
3. Periti P, Mini E, Mosconi G. Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. J Antimicrob Chemother. 1998; 41(3):329-340. (Pubitemid 28151981)
4. Periti P, Stringa G, Mini E. Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery. Eur J Clin Microbiol Infect Dis. 1999; 18(2):113-119.
5. Sugarman B, Young EJ. Infections associated with prosthetic devices: magnitude of the problem. Infect Dis Clin North Am. 1989; 3(2):187-198.
6. Mader JT, Landon GC, Calhoun J. Antimicrobial treatment of osteomyelitis. Clin Orthop Relat Res. 1993; (295):87-95.
7. Ostermann PA, Henry SL, Seligson D. Timing of wound closure in severe compound fractures. Orthopedics. 1994; 17(5):397-399. (Pubitemid 24145491)
8. Price JS, Tencer AF, Arm DM, Bohach GA. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res. 1996; 30(3):281-286. (Pubitemid 26071916)
9. Seligson D, Klemm K. Adult posttraumatic osteomyelitis of the tibial diaphysis of the tibial shaft. Clin Orthop Relat Res. 1999; (360):30-36. (Pubitemid 29140932)
10. Maurer DJ, Merkow RL, Gustilo RB. Infection after intramedullary nailing of severe open tibial fractures initially treated with external fixation. J Bone Joint Surg Am. 1989; 71(6):835-838.
11. Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect. 2001; 49(2):87-93. (Pubitemid 32982681)
12. Green SA. Complications of external skeletal fixation. Clin Orthop Relat Res. 1983; (180):109-116.
13. Ahlborg HG, Josefsson PO. Pin-tract complications in external fixation of fractures of the distal radius. Acta Orthop Scand. 1999; 70(2):116-118. (Pubitemid 29221712)
14. Garberina MJ, Fitch RD, Hoffmann ED, Hardaker WT, Vail TP, Scully SP. Knee arthrodesis with circular external fixation. Clin Orthop Relat Res. 2001; (382):168-178. (Pubitemid 32047443)
15. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004; 350(14):1422-1429. (Pubitemid 38419996)
16. Flock JI, Brennan F. Antibodies that block adherence of to fibronectin. Trends Microbiol. 1999; 7(4):140-141.
17. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M. Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res. 2001; 58(4):449-455. (Pubitemid 32643194)
18. Schmidmaier G, Wildemann B, Bail H, et al. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone. 2001; 28(4):341-350.
19. Hutmacher D, Hürzeler MB, Schliephake H. A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int J Oral Maxillofac Implants. 1996; 11(5):667-678. (Pubitemid 126442774)
20. Kulkarni RK, Moore EG, Hegyeli AF, Leonard F. Biodegradable poly(lactic acid) polymers. J Biomed Mater Res. 1971; 5(3):169-181.
21. Kulkarni RK, Pani KC, Neuman C, Leonard F. Polylactic acid for surgical implants. Arch Surg. 1966; 93(5):839-843.
22. Gollwitzer H, Ibrahim K, Meyer H, Mittelmeier W, Busch R, Stemberger A. Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. J Antimicrob Chemother. 2003; 51(3):585-591. (Pubitemid 36336150)
23. Acar JF, Goldstein FW. Disk susceptibility test. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 3rd ed. Baltimore, MD: Lippincott Williams & Wilkins; 1991:17-52.
24. Harris LG, Richards RG. Staphylococci and implant surfaces: a review. Injury. 2006; 37(suppl 2):S3-14.
25. Checketts R, Otterburn M, MacEachern G. Pin track infection: definition, incidence and prevention. Int J Orthop Trauma. 1993; 3(3):16-18.
26. Mahan J, Seligson D, Henry SL, Hynes P, Dobbins J. Factors in pin tract infections. Orthopedics. 1991; 14(3):305-308.
27. Hargreaves DG, Pajkos A, Deva AK, Vickery K, Filan SL, Tonkin MA. The role of biofilm formation in percutaneous Kirschner-wire fixation of radial fractures. J Hand Surg Br. 2002; 27(4):365-368.
28. Worlock P, Slack R, Harvey L, Mawhinney R. The prevention of infection in open fractures: an experimental study of the effect of fracture stability. Injury. 1994; 25(1):31-38. (Pubitemid 24014855)
29. Bagno A, Genovese M, Luchini A, et al. Contact profilometry and correspondence analysis to correlate surface properties and cell adhesion in vitro of uncoated and coated Ti and Ti6Al4V disks. Biomaterials. 2004; 25(12):2437-2445. (Pubitemid 38102397)
30. Barth E, Myrvik QM, Wagner W, Gristina AG. In vitro and in vivo comparative colonization of Staphylococcus aureus and Staphylococcus epidermidis on orthopaedic implant materials. Biomaterials. 1989; 10(5):325-328.
31. von Eiff C, Proctor RA, Peters G. Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med. 2001; 110(4):63-76.
32. Richards RG, Harris LG, Schneider E, Haas N. Antiseptics and antibiotics on implants. Injury. 2006; 37(2 suppl 1):S113-S116.
33. Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury. 2006; 37(suppl 2): S105-112.
34. Kälicke T, Schierholz J, Schlegel U, et al. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. J Orthop Res. 2006; 24(8): 1622-1640. (Pubitemid 44203294)